To Get Help Now
Click Here
 
Today's Date:

Parker Waichman Alonso File Actos Lawsuit

AddThis Social Bookmark Button

The national law firm of Parker Waichman Alonso LLP, has filed a lawsuit on behalf of Clement Dabiere, against Takeda Pharmaceuticals America, Inc., Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceutical Company Limited, and Eli Lilly and Company, alleging that as a result of using the diabetes drug Actos, Dabiere was diagnosed with and continues to suffer from bladder cancer.

According to the lawsuit, Dabiere began taking Actos in 2006, to treat type 2 diabetes. Diabere alleges that they defendants concealed their knowledge that Actos can cause bladder cancer from consumers, and have yet to inform the medical community and consumers that taking Actos for more than 12 months increases the risk of bladder cancer.

Actos was approved by the FDA in 1999 to treat type 2 diabetes. However, in 2010, the FDA issued a safety announcement saying it was reviewing data from an ongoing ten year study to evaluate the association between Actos and bladder cancer.

On June 15, 2011, the FDA issued another Safety Announcement stating that “use of the diabetes medication ACTOS (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.”

The lawsuit claims severe, permanent and life threatening personal injuries, pain, suffering, emotional distress, lifelong fear of premature death and the need for continued lifelong treatment and medications, and seeks damages in excess of $150,000.

 

 

breakinglawsuitnews.com disclaimer: This article: Parker Waichman Alonso File Actos Lawsuit was posted on Friday, September 2nd, 2011 at 7:58 pm at breakinglawsuitnews.com and is filed under Defective Drug Lawsuits.

« »

Leave a Reply

You must be logged in to post a comment.